表紙:バイオサージェリーの世界市場
市場調査レポート
商品コード
1193976

バイオサージェリーの世界市場

Biosurgery

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 179 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
バイオサージェリーの世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のバイオサージェリーの市場規模は、2022年に118億米ドルとなり、2022年~2030年の分析期間にかけて4.3%のCAGRで拡大し、2030年に166億米ドルとなると予想されています。

当レポートでは、世界のバイオサージェリー市場を調査し、市場の概要、市場の促進要因の分析、市場機会、地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州
  • アジア太平洋地域
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP10738

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biosurgery Market to Reach $16.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biosurgery estimated at US$11.8 Billion in the year 2022, is projected to reach a revised size of US$16.6 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2022-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$6.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hemostatic Agents segment is readjusted to a revised 3.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 4% CAGR

The Biosurgery market in the U.S. is estimated at US$3.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Select Competitors (Total 12 Featured):

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding B.V. & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi U.S.
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biosurgery Market to Witness Steady Growth
    • Percentage Market Share of Worldwide Bio-Surgeries by Country: 2015 and 2022
    • Bone Graft Substitutes to Account for Largest Share
    • North American Region to Dominate Market Growth
    • Worldwide Biosurgery Market: Breakdown of Total Sales Value (in Billion USD) by Region: 2015 and 2022
    • Biosurgery - Global Key Competitors Percentage Market Share in 2022 (E)
    • A Prelude into Leading Players
    • Global Biosurgery Market: Percentage Breakdown of Market Shares by Leading Players: 2018
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • New Approvals to Support Market Growth
    • Various Strategies from Leading Players to Bolster Market Growth
    • Rapid Growth in Ageing Population Drives Market Growth
    • Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E)
    • Rise in Worldwide Surgical Procedures to Fuel Market Growth
    • Total Number of Surgical Procedures Performed (in Millions) Per Annum in the US: 1981-2015
    • Total Number of Surgical Procedures Performed for Inpatients in Europe per Annum: 2001-2015
    • Rising Incidence of Injuries due to Trauma Supports Market Growth
    • Myriad Health End-Users to Drive Market Growth
    • Percentage Breakdown of Biosurgery Market Shares by Application: 2018
    • Percentage Growth Rate of Various Bio-Surgical Products in Wound-Closure Segment: 2011-2017
    • Innovations to Spur Market Growth
    • Total Sales of DermaPure: 2016-2018
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Biosurgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Soft Tissue Attachments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Reconstructive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Gynecological Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: France 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2014, 2023 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION